Used as an intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to form biaryl compounds. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in the development of active pharmaceutical ingredients (APIs). The morpholino carbonyl moiety enhances solubility and influences the electronic properties of the target molecule, aiding in the optimization of drug candidates for improved metabolic stability and bioavailability. Commonly applied in research settings for constructing complex organic molecules in medicinal chemistry.